Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer’s Disease

Figure 3

The receiver operating characteristic (ROC) curve analysis for discriminative ability between Alzheimer’s disease (AD) cases and nondementia controls (NC) enrolled in the training and validation sets by the 4 miRNAs and their panel. ROC curves for the 4 miRNAs and the 4-miRNA panel to separate 48 AD cases from 48 NC in the training set (a–e) and 79 AD cases from 75 NC in the validation set (f–j).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)